DESOXIMETASONE News

DESOXIMETASONE currently has 8 news articles, with 25 predicted indications.

This page combines the AI-predicted indications for DESOXIMETASONE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (25):
- primary cutaneous T-cell non-Hodgkin lymphoma (99.0%)
- neurodermatitis (99.0%)
- lupus erythematosus (99.0%)
- granuloma annulare (99.0%)
- exanthem (disease) (99.0%)
- occupational dermatitis (99.0%)
- atopic eczema (99.0%)
- dermatitis, atopic (99.0%)
- contact dermatitis (99.0%)
- seborrheic dermatitis (99.0%)
- discoid lupus erythematosus (99.0%)
- chronic cutaneous lupus erythematosus (99.0%)
- primary cutaneous T-cell lymphoma (99.0%)
- lichen disease (99.0%)
- seborrheic keratosis (99.0%)
- alopecia areata (99.9%)
- alopecia mucinosa (99.9%)
- telogen effluvium (99.9%)
- hereditary hypotrichosis with recurrent skin vesicles (99.9%)
- Quinquaud's folliculitis decalvans (99.9%)
- alopecia antibody deficiency (99.9%)
- alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome (99.9%)
- primary cutaneous B-cell lymphoma (99.6%)
- atrichia with papular lesions (99.6%)
- vulvar inverted follicular keratosis (99.2%)